Pfizer launches Kovid-19 vaccine delivery trials in four US states. Coronavirus


Pfizer has launched a pilot delivery program for its experimental Kovid-19 vaccine in four US states, as the drugmaker seeks to address delivery challenges posed by its ultra-cold storage requirements.

The American drugmaker said Rhode Island, Texas, New Mexico and Tennessee were chosen for the program because of differences in overall size, population diversity, and vaccination infrastructure, as well as states in various urban and rural areas There is a need to reach people. Adjustment.

Pfizer said in a statement, “The four states involved in this pilot program will not receive vaccine supplements earlier than other states by virtue of this pilot, nor will they be considered a difference.”

“We hope that the results from this vaccine delivery pilot will serve as a model for other US states and international governments as they prepare to implement effective Kovid-19 vaccine programs.”

A week ago, Pfizer released preliminary data on its vaccine, developed with German partner BioNTech SE, stating that it is more than 90% effective.

Pfizer vaccines must be shipped and stored at -70 ° C (-94 ° F), far below the standard for vaccines of two to eight ° C (36–46 ° F).

Earlier on Monday, rival Modern Inc. said its experimental vaccine, 94.5% effective at stopping Kovid-19 based on interim data from a late-stage trial, is hopeful that the vaccine against the disease will be ready for use soon Can occur. The modern vaccine does not require ultracold freezing, a factor that could prove to be a major advantage over Pfizer’s product.

Both Pfizer and Modern use a new technology called synthetic messenger RNA to activate the immune system against vaccine viruses.

Experts have raised concerns about distribution challenges associated with Pfizer’s vaccine due to its special storage requirements.

An outbreak of optimism that a vaccine could soon control coronaviruses and the economic devastation it caused, the Dow Jones Industrial Average rose Monday for the first time in a record nine months.

In this way there were stocks of leading companies that would benefit from the economy falling out of their forced hibernation, such as airlines, movie theaters and banks.

Epidemic winning stocks that benefited from lockdown orders such as Amazon and Zoom Video Communications, as they no longer appeared to play only safe bets.

The Dow jumped 470.63 points or 1.6% to 29,950.44 points. It surpassed the earlier closing record of 29,551.42 set in February, before epidemic-prone stocks dipped in February.

With Reuters and AP

Leave a Reply